{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T03:09:28Z","timestamp":1780628968281,"version":"3.54.1"},"reference-count":13,"publisher":"Japan Endocrine Society","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2022]]},"DOI":"10.1507\/endocrj.ej22-0066","type":"journal-article","created":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T18:09:22Z","timestamp":1655834962000},"page":"1323-1328","source":"Crossref","is-referenced-by-count":3,"title":["Subclinical acromegaly: to treat or not to treat?"],"prefix":"10.1507","volume":"69","author":[{"given":"Ilan","family":"Shimon","sequence":"first","affiliation":[{"name":"Institute of Endocrinology, Rabin Medical Center - Beilinson Hospital, Petach Tikva 4941492, Israel"},{"name":"Sackler School of Medicine, Tel-Aviv University, Tel Aviv 6997801, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaina","family":"Adnan","sequence":"additional","affiliation":[{"name":"Zvulun Medical Center, Clalit Medical Services, Kiryat Bialik 2706716, Israel"},{"name":"Azrieli Faculty of Medicine, Bar Ilan University, Sefad 1311502, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dania","family":"Hirsch","sequence":"additional","affiliation":[{"name":"Institute of Endocrinology, Rabin Medical Center - Beilinson Hospital, Petach Tikva 4941492, Israel"},{"name":"Sackler School of Medicine, Tel-Aviv University, Tel Aviv 6997801, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadar","family":"Duskin-Bitan","sequence":"additional","affiliation":[{"name":"Institute of Endocrinology, Rabin Medical Center - Beilinson Hospital, Petach Tikva 4941492, Israel"},{"name":"Sackler School of Medicine, Tel-Aviv University, Tel Aviv 6997801, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Akirov","sequence":"additional","affiliation":[{"name":"Institute of Endocrinology, Rabin Medical Center - Beilinson Hospital, Petach Tikva 4941492, Israel"},{"name":"Sackler School of Medicine, Tel-Aviv University, Tel Aviv 6997801, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Colao A, Grasso LFS, Giustina A, Melmed S, Chanson P, et al. (2019) Acromegaly. Nat Rev Dis Primers 5: 20.","DOI":"10.1038\/s41572-019-0071-6"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Holdaway IM, Bolland MJ, Gamble GD (2008) A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly. Eur J Endocrinol 159: 89\u201395.","DOI":"10.1530\/EJE-08-0267"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3 Caron P, Brue T, Raverot G, Tabarin A, Cailleux A, et al. (2019) Signs and symptoms of acromegaly at diagnosis: the physician\u2019s and the patient\u2019s perspectives in the ACRO-POLIS study. Endocrine 63: 120\u2013129.","DOI":"10.1007\/s12020-018-1764-4"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Melmed S, Bronstein MD, Chanson P, Klibanski A, Casanueva FF, et al. (2018) A consensus statement on acromegaly therapeutic outcomes. Nat Rev Endocrinol 14: 552\u2013561.","DOI":"10.1038\/s41574-018-0058-5"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Giustina A, Bevan JS, Bronstein MD, Casanueva FF, Chanson P, et al. (2016) SAGIT<sup>\u00ae<\/sup>: clinician-reported outcome instrument for managing acromegaly in clinical practice\u2014development and results from a pilot study. Pituitary 19: 39\u201349.","DOI":"10.1007\/s11102-015-0681-2"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Butz LB, Sullivan SE, Chandler WF, Barkan AL (2016) \u201cMicromegaly\u201d: an update on the prevalence of acromegaly with apparently normal GH secretion in the modern era. Pituitary 19: 547\u2013551.","DOI":"10.1007\/s11102-016-0735-0"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Espinosa de Los Monteros AL, Sosa-Eroza E, Gonzalez B, Mendoza V, Mercado M (2018) Prevalence, clinical and biochemical spectrum, and treatment outcome of acromegaly with normal basal GH at diagnosis. J Clin Endocrinol Metab 103: 3919\u20133924.","DOI":"10.1210\/jc.2018-01113"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8 Langlois F, Woltjer R, Cetas JS, Fleseriu M (2018) Silent somatotroph pituitary adenomas: an update. Pituitary 21: 194\u2013202.","DOI":"10.1007\/s11102-017-0858-y"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Wade AN, Baccon J, Grady MS, Judy KD, O\u2019Rourke DM, et al. (2011) Clinically silent somatotroph adenomas are common. Eur J Endocrinol 165: 39\u201344.","DOI":"10.1530\/EJE-11-0216"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Neggers SJ, Pronin V, Balcere I, Lee MK, Rozhinskaya L, et al. (2015) Lanreotide Autogel 120 mg at extended dosing intervals in patients with acromegaly biochemically controlled with octreotide LAR: the LEAD study. Eur J Endocrinol 173: 313\u2013323.","DOI":"10.1530\/EJE-15-0215"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Holdaway IM, Rajasoorya RC, Gamble GD (2004) Factors influencing mortality in acromegaly. <i>J Clin Endocrinol Metab<\/i> 89: 667\u2013674.","DOI":"10.1210\/jc.2003-031199"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Holdaway IM, Bolland MJ, Gamble GD (2008) A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly. Eur J Endocrinol 159: 89\u201395.","DOI":"10.1530\/EJE-08-0267"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Esposito D, Ragnarsson O, Johannsson G, Olsson DS (2020) Prolonged diagnostic delay in acromegaly is associated with increased morbidity and mortality. Eur J Endocrinol 182: 523\u2013531.","DOI":"10.1530\/EJE-20-0019"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/69\/11\/69_EJ22-0066\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T00:44:55Z","timestamp":1715301895000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/69\/11\/69_EJ22-0066\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":13,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej22-0066","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-639001\/v1","asserted-by":"object"}]},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]},"article-number":"EJ22-0066"}}